NL-OMON42959撤回不适用
Intra-arterial autologous myogenic stem cell therapy for m.3243A>G mutation carriers - MABs therapy m.3243A>G mutation carriers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult carriers of a m.3243A>G mutation in muscle >30%
排除标准
- •Significant concurrent illness
- •Pregnant or lactating women
- •Psychiatric or other disorders likely to impact on informed consent
- •Patients unable and/or unwilling to comply with treatment and study instructions
- •Any other factor that in the opinion of the investigator excludes the patient from the study
- •Allergy contrast fluid
研究者
相似试验
进行中（未招募）
1 期
Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action studyknee osteoarthritisCTIS2023-506088-33-00Aarhus University80
招募中
1 期
Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action studyMedDRA version: 21.1Level: LLTClassification code: 10023476Term: Knee osteoarthritis Class: 10028395knee osteoarthritisCTIS2023-506088-33-01Aarhus University80
招募中
不适用
Intra Coronary Autologous Stem Cell Transplantation in Acute Myocardial Infarction (AMICTRI/2010/091/000643Global Medical education & Research Center50
已完成
不适用
Assess safety of intra-arterial autologous myogenic stem cell therapy for m.3243A>G mutation carriersmitochondrial myopathymitochondrial muscular disease10028302NL-OMON50120Medisch Universitair Ziekenhuis Maastricht15
招募中
2 期
Intravenous infusion of autologous mesenchymal stem cells from bone marrow for chronic brain injury patients (PhaseII)Chronic brain injuryJPRN-jRCT1090220333Osamu Honmou, MD, PhD10